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ABSTRAK 
Bahasa Malaysia. 
Topik: Analisa Hayat dan Kesan Akhir Rawatan Pembedaban bagi Pesakit 
Perdarahan Intraserebral Spontan. 
Objektif. 
Matlamat penyelidikan ini ialah untuk menilai peranan rawatan pembedahan bagi 
perdarahan intraserebral spontan dan mengenalpasti factor-faktor radiologi, genetik, 
biokemikal dan rawatan di dalam menentukan jangka hayat dan kesan akhir rawatan. 
Prosedur Kaiian. 
Kajian ini ialah kajian prospektifkohot, termasuk pesakit yang mengalami perdarahan 
intraserebral spontan yang menepati kriteria untuk rawatan pembedahan. Kajian ini 
dijalankan untuk tempoh 13 bulan, dari Februari 2004 sehingga Mac 2005.Rawatan 
pembedahan ini dilakukan secara kaedah kraniotomy dan teknik mikrosurgeri dan 
bagi sesetengah kes, kaedah kraniektomi dekompresif.Ventrikulostomi untuk: 
mengukur tekanan otak dan mengeluarkan darah, kaj ian pengaliran darah otak dan 
mikrodialisis untuk pengukuran tahap laktat:pyruvat dijalankan untuk: setiap pesakit. 
Kajian habungkait diantara Apolipoprotein E e4 dan kesannya keatas pesakit juga 
dilakukan. Pengukuran akhir kajian ini ialah jangka hayat dan kesan akhir rawatan 
berdasarkan kepada 'Glasgow Outcome Scale' (GOS). GOS I-III didefinasikan 
sebagai kesan akhir yang tidak baik dan GOS IV-V didefinasikan sebagai kesan akhir 
yang baik. Faktor-faktor klinikal, radiologikal, genetik, biokemikal dan rawatan yang 
menentukan jangka hayat pesakit dan pencapaian fungsi dianalisa bagi mengenalpasti 
factor yang signifikan. Analisa univariat bagi factor-faktor kajian dan 'GOS' pada 
masa 6 bulan dilakukan dengan kaedah 'chi-square' dan analisa kesan hayat 
menggunakan ujian 'Kaplan Meier' dan 'log-rank'. Bagi analisa multivariat, kaedah 
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'binary logistic regression' digunakan untuk kesan akhir rawatan dan 'Cox regression' 
untuk kesan hayat. 
Keputusan. 
36 pesakit telah terlibat didalam kajian bagi tempoh diantara bulan Februari 2004 dan 
Mac 2005. Perkembangan semua pesakit dilihat untuk tempoh 6 bulan. Kajian ini 
mempunyai 19 pesakit lelaki and 16 pesakit perempuan yang berumur diantara 39 dan 
76 tahun dengan purata umur 58.6 tahun .Sebanyak 27 (75%) pesakit mempunyai 
'Glasgow Coma Score' diantara 5 ke 8 dan 9 (25%) pesakit mempunyai 'Glasgow 
Coma Score' 9. Tempoh hayat pesakit didalam kajian adalah diantara 2 ke 180 hari, 
dengan purata 105.36 ± 76.4 hari. Pada tempoh 6 bulan, 20 (55.6%) pesakit 
mempunyai GOS I, 1 (2.8%) pesakit mempunyai GOS II, 10 (27.7%) pesakit 
mempunyai GOS III dan 5 (13.9%) pesakit mempunyai GOS of IV. Tiada pesakit 
didalam kajian mempunyai GOS V. Kadar kematian pada 6 bulan ialah 55%. 86% 
pesakit mendapat kesan akhir yang tidak baik (GOS I-III) dan 14% mendapat kesan 
akhir yang baik (GOS IV-V). Kajian Apolipoprotin E menunjukkan tiada pesakit 
mempunyai allel APOE e4.Didalam analisa univariat untuk menentukan pencapaian 
fungsi pada masa 6 bulan berasaskan kepada 'GOS' menunjukkan 3 variabel yang 
signiftkan iaitu 'anjakan tengah' (p=0.009), 'pengaliran setempat serebral'(p=0.034) 
dan 'status trakeostomi'(p=0.047). Analisa univariat untukjangka hayat menunjukkan 
'pengaliran setempat serebral'(p=O.Ol43), 'anjakan tengah'(0.0064) dan status pupil 
(p=O.OO 16) pesakit adalah 3 faktor yang signifikan dalam menentukan jangka hayat. 
Variabel-variable yang terpilih ini akan dimasukkan ke dalam analisa 'binary logistic 
regression' dan analisa 'Cox regression' untuk menentukan factor yang paling 
signifikan dalam kesan akhir rawatan dan jangka hayat. Anjakan tengah dikanalpasti 
sebagai factor signifikan didalam menentukan kesan akhir rawatan pada 6 bulan 
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(OR=20.8; 95% CI = 1.90-227.26; p=0.013), dan status pupil dikenalpasti sebagai 
factor penting didalam menentukan kesan hayat (HR = 2.298; 95% CI 1.168- 4.523; 
p=O.O 16). Pesakit yang mempunyai anjakan tengah > 5 mm mempunyai 21 kali 
kemungkinan untuk mendapat kesan akhir yang tidak baik (GOS I-ll) dan pesakit 
yang mempunyai pupil yang tidal normal mempunyai risiko kematian sebanyak 2.3 
kali jika dibandingkan dengan pesakit yang mempunyai pupil yang normal. 
Kesimpulan. 
Rawatan pembedahan untuk pesakit intraserebral hanya memberi faedah kepada 
sebilangan kecil pesakit dimana 14% mendapat pencapaian fungsi yang baik dan 86% 
pesakit mendapat pencapaian fungsi yang tidal baik. Pesakit yang mempunyai anjakan 
tengah > 5 mm mempunyai 21 kali kemungkinan untuk mendapat kesan akhir yang 
tidak baik (GOS I-III) dan pesakit yang mempunyai pupil yang tidal normal 
mempunyai risiko kematian sebanyak 2 kali ganda jika dibandingkan dengan pesakit 
yang mempunyai pupil yang normal. 
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ABSTRACT 
Title: Survival Analysis and Functional Outcome at 6 months in Surgical 
Treatment of Spontaneous Supratentorial Intracerebral Hemorrhage CICID. 
Objectives. 
The aim of this study is to evaluate the role of surgery in patients with spontaneous 
supratentorial intracerebral hemorrhage and to identify predictors of outcome and 
survival including radiological, genetic, biochemical and treatment factors. 
Study design and method. 
This is a prospective cohort study, involving patients with spontaneous supratentorial 
intracerebral hemorrhage, who fulfill the inclusion criteria for surgical evacuation of 
the hematoma. This study was conducted over a 13 month period, from February 
2004 to March 2005 .Surgery consisted of evacuation of hematoma using craniotomy 
and microsurgical techniques, as well as in some cases, a decompressive craniectomy. 
The ventriculostomy for intracranial pressure monitoring and drainage and regional 
cortical cerebral blood flow (rCoBF) monitoring and microdialysis were performed in 
all subjects. In addition, the association between Apolipoprotein E (APOE) s4 and 
outcome was also studied. The study end points were survival time and functional 
outcome at 6 months based on a dichotomised Glasgow Outcome Scale (GOS). GOS 
of 1-3 was defined as poor or unfavorable outcome and GOS of 4-5 was defined as 
good or favorable outcome. The selected clinical, radiological, genetic, biochemical 
and treatment factors that may influence the survival and functional outcome were 
analysed for its significance. The univariate analysis of the relation between various 
variables and GOS at 6 months were analysed using the chi-square test and the 
survival time was analysed using the Kaplan Meier and log rank test. In multivariate 
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analysis, the binary logistic regression for functional outcome and Cox regression 
analysis for survival function were performed. 
Results. 
36 patients were recruited into the study during the period of February 2004 and 
March 2005. All of those were followed-up for a period of 6 months. There were 19 
males and 17 females with age ranged from 39 to 76 years and a mean age of 58.6 
(±10.1) years and a median age of 61 years. 27(75%) patients had Glasgow Coma 
Score (GCS) between 5 to 8 on admission and 9(25%) were admitted with GCS of 9 
on admission. The survival time ranged from 2 to 180 days with a mean survival time 
of 105.36 ± 76.4 days. At 6 months, 20 (55.6%) patients had GOS I, 1 (2.8%) patient 
had GOS II, 10 (27.7%) patients had GOS III and 5 (13.9%) had GOS of IV. None of 
the patients in this study had GOS ofV. The mortality rate at 6 months was 55%. 86 
%had a poor or unfavorable outcome (GOS I-III) and 14% had good or favorable 
outcome (GOS IV-V). The study of Apolipoprotein E showed that the APOE e4 allele 
was not detected in all patients. In the univariate analysis for the functional outcome 
based on GOS, 3 significant variables were identified, the midline shift (p=0.009), 
regional cortical cerebral blood flow (rCoBF), (p=0.034) and tracheostomy status 
(p=0.047). The univariate analysis for survival function revealed that the regional 
cortical cerebral blood flow (rCoBF), (p=0.0143), midline shift (p=0.0064) and 
pupillary status on admission (p=0.0016) were significant predictors of survival 
function. The selected variables were then incorporated into models generated by 
binary logistic regression and Cox regression analysis to identify significant 
predictors of functional outcome and survival function. Midline shift was the single 
significant predictor of functional outcome at 6 months (OR=20.8; 95% CI = 1.90-
227.26; p=0.013), and the pupillary status was sole significant predictor of survival 
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function (HR = 2.298; 95% CI 1.168- 4.523; p=0.016). Patients with midline shift> 
5mm has almost 21 times higher chances of being associated with poor outcome 
(GOS I-III) and patients with abnormal pupil on admission has 2.3 times risk of 
mortality compared to patients with normal pupillary reaction on admission. 
Conclusion. 
Surgical treatment for spontaneous intracerebral hemorrhage in this group of patients 
only benefited a small number of patients in terms of favorable outcome (14%) and in 
the majority of patients (86% ), the outcome was unfavorable. Patients with midline 
shift > 5mm has almost 21 times higher chances of being associated with poor 
outcome (GOS 1-111) at 6 months and patients with an abnormal pupil on admission 
had an increase in mortality risk of about 2 times compared to patients with normal 
pupiJJary reaction on admission. 
xiii 
l.INTRODUCTION. 
Intracerebral hemorrhage (ICH) is bleeding that occurs directly into the brain 
parenchyma. It is differentiated from intraventricular hemorrhage (IVH) and SAH, 
which involve bleeding into the brain's ventricular system and subarachnoid space, 
respectively. Often, ICH is classified as primary (unrelated to congenital or acquired 
lesions), secondary (directly related to congenital or acquired conditions), and/or 
spontaneous (not secondary to trauma or surgery). It is a common devastating 
neurologic event that causes high morbidity and mortality with profound economic 
complications. Unlike the declining mortality with subarachnoid hemorrhage due to 
improvements in surgical and critical care techniques, the morbidity and mortality of 
ICH have remained relatively unchanged throughout the past several decades. The 
role of medical and surgical treatment in ICH continues to be controversial. Studies of 
surgical hematoma evacuation in ICH using a variety of methods have yielded either 
negative or inconclusive results. Likewise, no medical treatment has been shown 
conclusively to benefit patients with ICH. 
This study is the first prospective cohort study in Malaysia assessing the role of 
surgery in the treatment of spontaneous supratentorial intracerebral hemorrhage in 
combination with best medical therapy in a selected group of patients meeting the 
inclusion and exclusion criteria for the study. This study was also conducted to 
identify associated clinical, radiological, genetic, biochemical and treatment factors 
that could significantly determine the survival time and functional outcome following 
surgical therapy for ICH. 
The study of Apolipoprotein E for the detection of APOE e4 allele, cerebral 
autoregulation test using transcranial Doppler sonography (TCD) and the thigh cuff 
technique was performed in all subjects on admission to intensive care unit. In some 
patients, an applanation tonometry assessing the central systemic haemodynamic by 
measuring the aortic augmentation index using the Pulse Wave Analysis (PWA) 
system was done. 
All patients in this study underwent an open craniotomy or decompressive 
craniectomy and hematoma evacuation. In addition, an intraventricular catheter for 
intracranial pressure (ICP) monitoring and drainage, intracerebral microdialysis 
catheter for monitoring of brain chemistry using lactate:pyruvate ratio and Saber 2000 
cerebral blood flow (CBF) sensor for measurement of regional cortical blood flow 
(rCoBF) was inserted on the cortical surface in all patients. After the surgery, all 
patients were admitted to the intensive care unit and a standard medical therapy was 
provided. 
The outcome of interest were dichotomized Glasgow Outcome Scale (GOS) into good 
or favourable outcome (GOS IV - V) and bad or unfavourable outcome (GOS I, II 
and III) and the survival analysis based on time to event which is the duration of 
patient died after intervention. 
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2.LITERA TURE REVIEW. 
INTRODUCTION. 
Spontaneous supratentorial intracerebral hemorrhage (ICH) is bleeding into the 
parenchyma of the brain that may extend into the ventricles and in rare cases, the 
subarachnoid space. Intracerebral hemorrhage (ICH) accounts for 10 to 15 % of all 
cases of stroke and is associated with disproportionately high morbidity and mortality. 
It is associated with the highest mortality rate, with only 3 8% of affected patients 
surviving the first year. 1 Depending on the underlying cause of bleeding, intracerebral 
hemorrhage is classified as either primary or secondary. Primary intracerebral 
hemorrhage, accounting for 78-88% of cases, originates from spontaneous rupture of 
small vessels damaged by chronic hypertension or amyloid angiopathy. 2 Secondary 
intracerebral hemorrhage occurs in a minority of patients in association with vascular 
abnormalities such as arteriovenous malformations and aneurysm, tumors, trauma or 
impaired coagulation. 
EPIDEMIOLOGIC FEATURES. 
Incidence. 
Intracerebral hemorrhage is common, with an estimated prevalence of 3 7,000 cases 
per year in the United States. 3 It is twice as prevalent as subarachnoid hemorrhage 
(SA H) and accounts for approximately 1 0% of all strokes. Incidence rates vary on the 
basis of age, race and demographics. The most recent population-based studies using 
computed tomography (CT) verification estimate that the overall incidence of ICH is 
between 12 and 15 cases per 100,000 population.4There is a slight male 
predominance. The incidence of ICH increase exponentially with increasing age, with 
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rates doubling every 10 years after age 35 years.5 The overall mean age for patients 
with ICH is 61 years. 
In contrast, ICH is more common in Asian, African and Hispanic American 
populations. Incidence rates are estimated to be twice as high in this populations. 6 The 
reason for the large discrepancy among among populations is unclear but probably is 
accounted for by differences in education, poor control of hypertension, and lack of 
health care availability. The population-based series from Asia, specifically from 
Japan which included thousands of stroke cases where hemorrhage accounted for 
approximately 25% of all strokes, and intraparenchymatous hemorrhage comprised 
two thirds of the total.7 In a prospective ASEAN-wide collaboration study of 3,200 
hospitalised stroke patients, 22% of all strokes were hemorrhagic. 8 In general, the 
frequency of hemorrhagic stroke ranges from 17.2% seen in Malaysia9 to 39% seen in 
Surabaya, Indonesia.10 Data for the incidence of hemorrhagic stroke among ASEAN 
countries is presented in Table 2.1. With respect to our local data, in 1994, the 
University Hospital Stroke Registry (UHSR) was established at the University 
Hospital Kuala Lumpur. Out of 413 cases of stroke, 71(17.2%) were due to 
intracerebral hemorrhage, 85% of patients had a history of hypertension. 
4 
Country Type ( Mixed urban and rural ) Hemorrhagic stroke (%) 
Malaysia Hospital based 17.2% 
Kelantan Hospital based 32.9% 
Indonesia Hospital based 38.6% 
Singapore Hospital based 26.0% 
Vietnam Community-wide 30.0% 
Thailand Hospital based 27.4% 
A SEAN Hospital based 22.3% 
Table 2.1: The frequency of hemorrhagic stroke tn A SEAN countrtes. 
Aetiologies of Spontaneous Intracerebral Hemorrhage. 
The etiologies of intracerebral hemorrhage are diverse, complex, and dynamic. 
Intracerebral hemorrhage secondary to pathologic changes initiated by chronic 
hypertension is responsible for approximately 75% of all cases of primary ICH.11 
More recent clinical and pathologic series have reported a lower percentage.12 
Cerebral amyloid angiopathy, the next most common cause of primary ICH is distinct 
from systemic amyloidosis and leads to the infiltration of amyloid protein into the 
media and adventitia of the cortical arterioles of the brain. Its prevalence increases 
with age; more than 60% of autopsy samples from patients older than 90 years exhibit 
some degree of amyloid deposition. Cerebral amyloid angiopathy is estimated to 
account for more than 20% of all ICH in patients older than 70 years.13 
Underlying vascular abnormalities such as arteriovenous malformations, cerebral 
aneurysms, or cavernous angiomas are an important cause of secondary ICH. The 
exact frequency of their occurrence is difficult to establish but may approximate 5% 
of all ICH. Vascular abnormalities occur primarily in younger populations, accounting 
for approximately 38% of ICH in patients younger than 45 years.14 Bleeding directly 
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into primary or metastatic brain tumors is another cause of secondary ICH but 
accounts for less than 10% of all ICH.15 
A growing source of secondary ICH, anticoagulant or fibrinolytic use accounts for 
approximately 10% of all ICH. Long term anticoagulant use increases the risk of ICH 
1 O-fold. 15 Sudden severe elevation in blood pressure is another source of ICH seen 
commonly in malignant hypertension but rarely after carotid endarterectomy. 
Intracranial hemorrhage due to cocaine, amphetamine, or phenylpropanolamine use 
may be secondary to sudden elevation in blood pressure, multifocal cerebral vessel 
spasm, or drug-induced cellulites.15 Secondary hemorrhages into brain areas after 
ischemic stroke or due to cerebral venous thrombosis can occur and reflect bleeding 
into compromised brain. Small areas of microhemorrhage can coalesce in a delayed 
fashion after severe head trauma. This occurs commonly at gray and white matter 
interfaces and usually reflects substantial pathologic damage. 
Risk Factors. 
A meta analysis on the risk factors for intracerebral hemorrhage in the general 
population by Ariesen et al. 16 identified 4 significant risk factors for ICH: 
hypertension, age, male sex and alcohol intake. Current smoking and diabetes mellitus 
are weak risk factors. Data are inconclusive for physical activity. Ever smoking was 
no risk factor. Data for hypercholesterolemia were conflicting. However, cumulative 
data on cholesterol suggested a lower risk of ICH with higher cholesterol level. In 
addition to the various factors mentioned above, genetic study of primary 
intracerebral hemorrhage have begun to yield important biologic insights into the 
pathogenesis of ICH. 
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(l)Hypertension. 
The most notable and modifiable risk factor for ICH is the presence ofhypertension.17 
Hypertension, detected in most patients with ICH, is the basis for the term 
hypertensive hemorrhage. Hypertension is the single most important modifiable risk 
factor for ICH. Approximately 75% of ICH patients have pre-existing hypertension.18 
Local study by Muiz et. al19 reported that hypertension was seen in 60.7% of patients 
with ICH. The investigator of 11 case-control studies showed a positive association 
between hypertension and ICH.16 The overall OR was 3.68 (95% CI, 2.52 to 5.38). 
Retrospective studies have shown that high blood pressure confers a two to six fold 
increase in the risk of ICH.20 Patients with recognized hypertension who discontinued 
their anti-hypertensives have a twofold increase in the risk of ICH relative to those 
who remain compliant with medication. Risk of ICH in patients with preexisting 
hypertension appears to be related to the severity and duration of hypertension. The 
exact quantification of risk is difficult to ascertain, but a response curve similar to the 
pack-year concept with smoking probably exists.4 
(2)Age and Sex. 
The incidence of ICH increases exponentially with increasing age, with rates doubling 
every I 0 years after age 35 years. 5 The overall mean age for patients with ICH is 61 
years. There is a slight male predominance. The investigator of 5 cohort studies 
reported on age and risk of ICH with the crude RR was 1.06. The RR for men 
compared to women was 4.64 (95% CI, 4.02 to 5.40). 16 
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(3)Alcohol. 
Several case-control studies have implicated heavy alcohol intake as a risk factor for 
ICH.21 This effect may be mediated partially by hypertension, although studies 
controlling for hypertension have supported an independent effect of alcohol. The 
reason for this may relate to impaired coagulation or platlet function or an increase in 
cardiac arrythmias leading to increased cardioembolic hemorrhagic infarctions.22 
Moderate alcohol use does not raise the risk, although there does appear to be a dose-
related increase in the odds-ratio of ICH?0 The investigator of 8 case-control studies 
reported on alcohol intake and association with ICH.16 Because the definition of high 
alcohol intake differed in the studies from > 36g/d to >I OOg/d , the authors arranged 
the studies according to cut off point from low to high. The overall OR was 
interpreted at an approximate mean cutoff of 56g/d, the weighted mean. The OR at 
this cutoffwas 3.36 (95%CI, 2.21 to 5.12). These studies indicate a possible trend of 
higher risk ofiCH with higher alcohol intake. 
(4)Smoking and Diabetes Mellitus. 
Metaanalysis by Arisien et al.16 concluded that current smoking and diabetes mellitus 
are weak risk factors for ICH. Ever smoking was no risk factor. The overall OR for 
current smoking was 1.25 (95% Cl, 0.94 to 1.66). The overall OR for diabetes 
mellitus was 1.27 (95% CI, 0.98 to 1.65). 
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(5)Serum cholesterol. 
An association between low total serum cholesterol levels and ICH was initially 
observed in Japanese patients. 7 Other studies have shown low cholesterol to be 
associated with increased rate of ICH only in combination with other risk factors 
including age and hypertension.23 The Multiple Risk Factor Intervention Trial24 and a 
recent case control studr5 reported that cholesterol level lower than 160 mg/dl 
imparted a 3-fold increase risk of ICH in hypertensive middle-aged men. 
Nevertheless, the precise aetiological role of serum cholesterol in the pathogenesis of 
ICH is incompletely understood. Importantly, treatment of hypercholesterolemia does 
not appear to confer an increased risk ofhemorrhage.26 
(6) Genetic Risk factor for ICH. 
A study by O'Donnell et a127 reported that the presence of the epsilon 2 and epsilon 4 
alleles of the apolipoprotein E (APOE) gene was associated with a tripling of the risk 
of recurrent hemorrhage among survivors of lobar intracerebral hemorrhage related to 
amyloid angiopathy. These alleles are associated with increased deposition of beta-
amyloid protein and degenerative changes such as fibrinoid necrosis in the vessel 
wall. The expression of either allele appears to increase the risk of intracerebral 
hemorrhage by augmenting the vasculopathic effects of amyloid deposition in 
cerebral vessels. This two APOE alleles appear not only to increase the risk for 
cerebral amyloid angiopathy occurrence, but also to lower the age of first 
hemorrhage27 and to shorten the time to recurrent ICH. In 70 consecutive survivors of 
an initial lobar ICH studied by O'Donnell et. af7, carriers of APOE £2 or £4 reb led at 
2-year rate of 28% compared with only 10% for patients with the common APOE 
e3/e3 genotype. A study by Woo et ae8 on genetic and environmental risk factors for 
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intracerebral hemorrhage showed that the presence of APOE e2 and e4 associated 
with an adjusted odds ratio for lobar ICH of 2.3 in the studied population, accounting 
for attributable risk of 29% of all lobar ICH. His study also found that half of all cases 
of non-lobar ICH are attributable to hypertension. The presence of APOE e2 and e4 in 
non-lobar ICH was statistically not significant. His study supported the hypothesis 
that the pathogenesis of lobar ICH may differ from nonlobar ICH. 
PATHOPHYSIOLOGY. 
Intracerebral hemorrhages commonly occur in the basal ganglia, cerebral lobes, 
thalamus, brain stem predominantly the pons and cerebellum. In a consecutive series 
of 109 cases ofiCH, the most common site of bleeding were the basal ganglia (42%), 
lobar (40%), cerebellum (8%), brain stem (6%) and thalamus (4%).29 Extension into 
the ventricles occurs in association with deep, large hematomas. Edematous 
parenchyma, often discolored by degradation products of hemoglobin, is visible 
adjacent to the clot. The anatomical location and computed tomographic images of the 
common sites of intracerebral hemorrhage is shown in Figure 2.1. 
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Figure 2.1: Anatomical location and computed tomographic images of the common 
sites of intracerebral hemorrhage.(A) Lobar or deep white matter, (B) Basal ganglia, 
(C) Thalamus, (D) Pons and (E) Cerebellum. (From Manno EM, Atkinson JLD, 
Fulgham JR, et al. Emerging medical and surgical management strategies in the 
evaluation and treatment of intracerebral hemorrhage. Mayo Ciin Proc. 
2005;80(3):420-433) 
Histologic sections are characterized by the presence of edema, neuronal damage, 
macrophages, and neutrophils in the region surrounding the hematoma.30 The 
hemorrhage spreads between planes of white matter cleavage with minimal 
destruction, leaving nests of intact neural tissue within and surrounding the 
hematoma. This pattern of spread accounts for the presence of viable and salvageable 
neural tissue in the immediate vicinity of the hematoma. 
Hypertensive intracranial hemorrhage occurs in areas of the brain that are perfused by 
the perforating arteries that arise directly from the large basal cerebral arteries. These 
perforating arteries are directly exposed to the effect of hypertension because they 
lack the protection normally afforded by a preceding gradual decrease in vessel 
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calibre.31 Chronic hypertension induces a series of pathologic changes that lead to 
segmental constriction of these vessels. This process was labeled lipohyalinosis by 
Fisher.32 
Lipohyalinosis represents 2 pathologic processes that include atherosclerosis of the 
larger (100-500 mm) perforating arteries and arteriosclerosis of the smaller (<100 
mm) perforating vessels. Atherosclerosis occurs most commonly at the branch point 
of vessels and is characterized by subintimal fibroblast proliferation accompanied by 
deposition of lipid-filled macrophages. Arteriosclerosis involves the replacement of 
smooth muscle cells in the tunica media with collagen. These processes result in the 
development of noncompliant, narrowed vessels that are susceptible to both sudden 
closure (lacunar infarction) or rupture that manifest as intracerebral hemorrhage. The 
mechanism of actual hemorrhage is presumably due to rupture of these fragile vessels, 
but this has been difficult to prove pathologically. Cerebral microaneurysms, 
described by Charcot and Bouchard33 and further delianeted by Fisher34 are described 
in only a small number of patients. Hemorrhagic expansion of fibrin or bleeding 
globules of tissue have been described but are believed to be limited to ICH secondary 
to sudden elevations in blood pressure. 
Intracerebral hemorrhage due to cerebral amyloid angiopathy (CAA) resulted from 
the deposition of the insoluble beta amyloid protein in the tunica media and adventitia 
of leptomeningeal and cortical arteries, arterioles and capillaries.35 Beta amyloid 
replaces the smooth muscles of the tunica media, making the artery less compliant. 
The presence of amyloid in blood vessels increases exponentially with age and is 
found in up to 58% of patients over the age of 90 years. CAA-related ICH in some 
cases may be related to an interaction with other risk factors, notably hypertension.36 
CAA -related hemorrhages are cortical or subcortically based, often large and have a 
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propensity for extension into the subarachnoid space and ventricles.37 Recurrence of 
lobar ICH is also indicative of amyloid angiopathy.38 It should be noted however that 
the diagnosis ofCAA can only reliably be made by histopathology.39 
The initial clinical effects of intracerebral hemorrhage are the result of direct 
destruction and displacement of surrounding brain tissue that occur during 
hemorrhage. The blood appears to dissect tissue planes, compressing adjacent 
structure. Initially, intracerebral hemorrhage was considered to be a monophasic event 
that stopped quickly as a result of clotting and tamponade by the surrounding regions. 
Subsequent neurologic deterioration was attributed to the development of cerebral 
edema. However, it is now accepted that a large percentage of patients will develop 
hemorrhagic expansion of their initial bleeding. Brott et al.40 in a prospective 
observational study of patients evaluated within the first 3 hours after ictus, described 
ICH expansion in 26% of patients within the first hour after hospital admission. 
Another I 2% of patients experienced ICH volume expansion within 20 hours after 
admission. Hematoma larger than 25 mls are more likely to grow in the first 6 hours 
from symptoms. Hematoma expansion after the first 24 hours is rare.41 The ICH 
volume can increase by as much as 40% and is associated with neurologic 
deterioration. A study by Kazui et a1.42 suggested that poorly controlled diabetes 
mellitus and systolic blood pressure greater than 200 mmHg on hospital admission 
were associated with hematoma volume expansion. 
The mechanisms of secondary tissue injury are less well defined. Rebleeding can 
occur, causing further tissue destruction and increased mass effect. Cerebral 
herniation can occur as a consequence of the hematoma mass effect. Hydrocephalus 
can develop and produce marked elevation in intracranial pressure, which may 
produce cerebral herniation. Ho,vever, the neurological deterioration after initial 
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hemorrhage is often attributed to the development of cerebral edama.43 An animal 
models of intracerebral hemorrhage have shown that blood is irritating to the 
parenchyma, and there is an area of edema, ischemia and hemorrhagic necrosis at the 
margin of the clot, so called the ischemic penumbra.44 Experimental studies in 
animals have suggested that early removal of mass lesion can reduce the ischemic 
damage.45 
The development of cerebral edema in ICH appears within hours secondary to clot 
retraction with extrusion of plasma protein into the underlying white matter.43 Later, 
delayed thrombin formation may contribute directly to neural toxicity or indirectly 
through damage to the blood-brain barrier with subsequent worsening of vasogenic 
edema. Peak edema occurs 3 to 7 days after the hemorrhage and correlates with lysis 
of red blood cells. Both hemoglobin and its degradation products have been 
implicated in direct and indirect neural toxicity.43 The importance of the development 
of cerebral edema in ICH has been supported by retrospective evidence suggesting 
that patients with a larger amount of cerebral edema relative to the initial hemorrhage 
volume have worse clinical outcome.46 
The role of ischemia in the pathophysiology of ICH is unclear. Numerous cerebral 
blood flow (CBF) studies have described an area of decreased perfusion surrounding a 
cerebral hemorrhage,47'48 suggesting that large areas of brain surrounding ICH may be 
at risk of ischemia. In 1988, Bullock et al.49 studied the effect on regional cerebral 
blood flow in a primate model of intracerebral hemorrhage. The study showed a 
profound reduction in cerebral blood flow in the hemisphere ipsilateral to the induced 
hematoma, and most markedly in the clot penumbra. The lowest regional cerebral 
blood flow values were recorded in the immediate clot penumbra and were below 
threshold levels for ischemic neuronal damage for 90 minutes after the hemorrhage. 
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Likewise, cerebral blood flow measurements in human after spontaneous intracerebral 
hematoma using single-photon emission computed tomographic scanning have also 
revealed reduced flow levels, with the greatest reduction in the ipsilateral hemisphere, 
however these regional cerebral blood flow levels were well above the threshold 
levels known to cause ischemic damage.47 Recent positron emission tomographic data 
have caused researchers to question the role of ischemia in ICH. Zazulia et al.50 
reported a normal oxygen extraction ratio in the perihematomal region, suggesting 
that this region is not ischemic and that the decreased perfusion occurs in response to 
decreased cerebral metabolism. A study by Peter et al.51 assessing the presence of 
perihemorrhagic ischemic changes in a prospective stroke magnetic resonance 
imaging (MRI) study found no evidence for a perihemorrhagic and potentially 
salvageable ischemic penumbra in hyperacute ICH. However the subjects in this study 
is small, severely ill and comatose patients was not included and the ICH size is 
smaller than in general population. 
CLINICAL PRESENTATION. 
The clinical presentation of ICH depends on the size, location, and presence of 
intraventricular extension of the hemorrhage. Headache of variable intensity always 
occurs and may be accompanied by nausea and vomiting, focal signs, and progressive 
neurological deficits. The deficits may not follow a typical infarction distribution 
pattern in patients with large artery stroke. Seizures occur in approximately I 0% of all 
patients with ICH and in almost one half of patients with lobar hemorrhage. Almost 
all seizures occur at the onset of bleeding or within the first 24 hours of ictus and are 
non predictive of the development of delayed epi1epsy.52 
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Patients harbour large hemorrhages usually present in stupor or coma. This may be 
secondary to elevated intracranial pressure (ICP) leading to decreased cerebral 
perfusion or due to direct infiltration or distortion of diencephalic or brainstem 
structures.53 Patients with blood extending into the ventricular system often 
experience a reduced level of alertness because of ventricular ependymal irritation or 
the development of hydrocephalus. 
In one fourth of patients with intracerebral hemorrhage who are initially alert, 
deterioration in the level of consciousness occurs within the first 24 hours after onset 
of cerebral hemorrhage.54 The presence of a large hematoma and ventricular blood 
increases the risk of subsequent deterioration and death. Expansion of the hematoma 
is the most common cause of underlying neurologic deterioration within the first three 
hours of the onset of hemorrhage. Worsening cerebral edema is also implicated in 
neurologic deterioration that occurs within 24-48 hours after the onset of 
hemorrhage. 55 Infrequently, late deterioration is associated with progression of edema 
during the second and third weeks after the onset. 56 
The classic presentation of ICH is sudden onset of a focal neurological deficit that 
progresses over minutes to hours with accompanying headache, nausea, vomiting, 
decreased consciousness, and elevated blood pressure. In the Harvard Stroke Registry, 
51% to 63% of patients with ICH had a smooth progression of neurological symptoms 
whereas 34% to 38% of patients had maximal symptoms at onset. By comparison, 
only 5% to 20% of the various ischemic stroke subtypes and 14% to 18% of patients 
with SAH had gradual progression of symptoms. 57 As previously mentioned, the early 
progression of neurological deficit in many patients with ICH is frequently due to 
ongoing bleeding and enlargement of hematoma during the firSt few hours.40 
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Patients with ICH uncommonly present with symptoms on awakening from sleep 
(15%).57 An early decrease in level of consciousness is seen in approximately 50% of 
patients with ICH, an uncommon early finding in patients with ischemic stroke. 
Vomiting is an important diagnostic sign, particularly if the hematoma lies within the 
cerebral hemisphere. The Harvard Stroke Registry reported that 49% of patients with 
supratentorial ICH vomited compared with 2% of patients with ischemia in the carotid 
territory and 45% of patients with SAH. 57 Elevation of blood pressure, often to very 
high levels, occurs in as many as 90% of patients with ICH. 
DIAGNOSIS. 
Despite the differences in clinical presentation between hemorrhagic and ischemic 
strokes, no collection of clinical features has sufficient predictive value to forego 
brain imaging. The diagnostic study of choice in ICH is noncontrasted Computed 
Tomography (Cn. CT scan clearly differentiates hemorrhagic from ischemic stroke. 
It also demonstrates the location of the hemorrhage and may reveal structural 
abnormalities such as aneurysms, arteriovenous amlformations, and brain tumors that 
cause ICH as well as structural. complications such as herniation, intraventricular 
hemorrhage, or hydrocephalus. Administration of contrast can often highlight 
suspected vascular abnormalities. The possible causes of hemorrhage can be 
determined by its location in the brain as seen on the CT scan, the presence of 
structural abnormalities as seen in brain imaging, associated medical conditions such 
as hypertension, and the patient's age. Hemorrhages that originate in the deep 
subcortical structures such as putamen, caudate, thalamus, pons, cerebellum, or 
periventricular deep white matter, particularly in patients with a history of 
hypertension result from rupture of the deep perforating arteries. Lobar intracerebral 
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hemorrhages in the very elderly are often thought to be due to amyloid angiopathy. 
However, this assumption may be incorrect, as in the majority of patients with lobar 
hemorrhage have a history ofhypertension.18 
Magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) 
have emerged as other useful tools for detecting structural abnormalities such as 
malformations and aneurysms. 58 Although MRI may miss small aneurysms and 
vascular malformations, it is superior to CT and angiography in detecting cavernous 
malformations. In addition, MRI is also useful for dating hemorrhages. MRI is 
limited in early detection of ICH by the time required to obtain imaging and by the 
limited ability to monitor a patient while in the scanner.59 
The role of cerebral angiography in ICH has been addressed by 3 studies. Zhu et al60 
reported low yield from cerebral angiography in identifying an underlying lesion in 
patients older than 45 years who had history of hypertension and had hemorrhages in 
deep subcortical structures. However, Halpin et al61 reported a different finding. He 
conducted a study to examine the role of angiography in ICH patients whose mean 
age was 49 years (range 1 0-70). CT findings that prompted the impression of a 
structural lesion were the presence of subarachnoid or intraventricular hemorrhage, 
abnormal intracranial calcification, prominent vascular structures, or the site of 
hemorrhage (eg, perisylvian hemorrhage). Of the 44 patients with these CT findings, 
38 underwent angiography. The angiographic findings were positive in 32 of the 38 
cases (84%) with identification of arteriovenous malformations in 23 patients and 
aneurysm in 9. Angiography was not performed for clinical reasons in 6 patients, and 
no abnormality was seen in the remaining 6. On the basis of CT findings, 58 patients 
were not thought to have an underlying structural lesion, but 42 underwent delayed 
angiography. Angiographic findings were positive in 10 patients in this group (24%), 
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revealing unsuspected arteriovenous malformation in 8 ( 19%) and aneurysm in 2 
(5%). In a study by Ishak et. a1,62 54 patients with an intracerebral hemorrhage who 
underwent both CT examination and six-vessel cerebral angiography were studied 
over a 2-year period. An angiography detected vascular lesion in 50% of cases, 38.9% 
aneurysm and 11.1% arteriovenous malformation (A VM). In the aneurysm group, 
angiographic yield was 34.3% and in the A VM group, it was 37.9%. His study 
suggested that cerebral angiography is justified in patients with pure subarachnoid 
hemorrhage (SAH). The diagnostic cerebral angiography is indicated for patients with 
ICH and SAH and IVH with a history ofhypertension, regardless of age. 
Other useful diagnostic tools include a complete blood count, prothrombin time, 
activated partial thromboplastin time, electrolytes, electrocardiography, and chest x-
ray. The white cell count can detect underlying infection such as hemorrhages 
associated with endocarditis. Hemoglobin analysis may also provide clues to 
diagnosis and as an indicator of blood loss. Prothrombin time and activated partial 
thromboplastin time may offer clues to coagulation problems, either iatrogenic or 
acquired. Electrolytes can reveal evidence of primary renal failure as an associated 
cause of ICH or disturbances in sodium that may accompany brain hemorrhage. 
Electrocardiography can reveal underlying dysrhythmia or myocardial ischemia 
associated with brain hemorrhage. Chest x-ray may reveal underlying aspiration or 
another pulmonic process that may complicate treatment. 
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MANAGEMENT. 
Due to lack of a proven medical or surgical treatment for ICH, there have been a great 
variation with regard to medical and surgical treatment for ICH.63 Although 
guide I ines based on scant data from randomized trials are uncertain at best and may 
be wrong at worst, they can provide a reasonable treatment approach at present. 
Initial Management in the Emergency Department. 
Initial management should first be directed towards the basic of airway, breathing, 
and circulation, and detection of focal neurological deficits. Examination should 
include looking for complications such as pressure sores, compartment syndromes, 
and rhabdom yo lysis in patients with prolonged depressed level of consciousness. The 
patient's level of consciousness must be monitored closely because neurologic 
deterioration can occur quickly with hematoma expansion or with rupture into 
ventricular system. 
Airway and Oxygenation. 
Although intubation is not required for all patients, airway protection and adequate 
ventilation are critical. Patients who exhibit a decreasing level of consciousness or 
signs of brain stem dysfunction are candidates for aggressive airway management. 
Intubation should be guided by imminent respiratory insufficiency rather than an 
arbitrary cutoff such as a specific Glasgow Coma Score (GCS). Intubation is indicated 
for insufficient ventilation as indicated by hypoxia (p02 <60 mmHg or PC02 > 50 
mmHg) or obvious risk of aspiration with or without impairment of arterial 
oxygenation. 
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Endotracheal intubation must be performed in a controlled setting by an experienced 
physician. Pharmacological agents and intubation techniques should be used to ensure 
rapid and smooth airway control along with medications designed to block increases 
in ICP. Lidocaine ( 1.0 - 2.0mglkg of body weight, or propofol, 10-20 mg in 
incremental doses) can be used for induction. Midazolam is generally avoided 
because of unfavorable effects on ICP during induction, although the clinical 
importance of this is uncertain. Neuromuscular paralysis ideally should be avoided 
and may be unnecessary in many instances. When required for airway control, a 
short-acting nondepolarizing agent such as atracurium besylate (0.3 -0.4 mglkg of 
body weight IV) or vecuronium bromide (0.2- 0.3 mglkg of body weight IV ) is 
preferred. Paralysis should be discontinued as quickly as possible to allow for 
monitoring of the neurologic examination. 59 Once the airway is secured, mechanical 
ventilation should be set to ensure adequate oxygenation and ventilation. If elevated 
ICP is suspected, an intermittent mandatory ventilation volume and rate should be set 
to attain a PC02 of 30 to 35 mmHg. Endotracheal tubes with soft cuffs can generally 
be maintained for <2 weeks. In the presence of prolonged coma or pulmonary 
complications, elective tracheostomy should be performed after 2 weeks. 
Medical Management. 
To date, 4 small randomized trial of medical therapy for ICH have been conducted. 
Steroid versus placebo treatment,64•65 hemodilution versus best medical therapy,66 and 
glycerol versus placebo.67 All these studies found no significant benefit for the 3 
therapies. In addition, Poungvarin et al64 reported that patients who were treated with 
steroids were more likely to develop infectious complications than those treated with 
placebo. Recently, Meyer et al68 conducted a randomized study assessing the role of 
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recombinant activated Factor VII (rFVIIa) for acute intracerebral hemorrhage in 399 
patients diagnosed by CT scan within 3 hours after the onset ofiCH. This study found 
that treatment with rFVIIa within four hours after the onset of hemorrhage limits the 
growth of the hematoma, reduces mortality and improved functional outcome at 90 
days, despite a small increase in the frequency of thromboembolic adverse events. 
Blood Pressure Management. 
The management of blood pressure in ICH is somewhat controversial. At present, the 
only guidelines for blood pressure management in ICH are provided by the AHA 
Stroke Council, which suggests acutely lowering mean arterial pressures > 
130mmHg.3 The optimal level of a patient's blood pressure should be based on 
individual factors such as chronic hypertension, elevated intracranial pressure (ICP), 
age, presumed cause of hemorrhage, and interval since onset. 
The theoretical rationale for lowering blood pressure is to decrease the risk of ongoing 
bleeding from ruptured small arteries or arterioles. However, a prospective 
observational study by Brott et a140 assessing the growth in the volume ofiCH did not 
demonstrate a relation between the baseline blood pressure and subsequent growth of 
ICH, but frequent use of hypertensive agents in this study may have obscured any 
relationship. Conversely, overaggressive treatment of blood pressure may decrease 
cerebral perfusion pressure and theoretically worsen brain injury, particularly in the 
setting of increased intracranial pressure. In a study by Abdullah J and colleagues69 
assessing the effect of management of reduction of hypertensive encephalopathy 
associated with intracerebral hemorrhage, they found that patients with systolic blood 
pressure between 140 to 160 mm Hg tolerated a mean blood pressure (MAP) of 60 
and lower and in patients with a higher systolic blood pressure of I 60-180 mm Hg, 
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they did not tolerate the MAP of 60 or less and required a MAP of 80 to I 00 mm Hg 
to maintain a cerebral blood flow (CBF) > 80ml/l OOg/min and a transcranial Doppler 
flow (TCD) of 50-I 00 em/sec. 
The AHA Stroke Council recommends that blood pressure levels be maintained 
below a mean arterial pressure of 130 mmHg in person with a history of hypertension. 
These guidelines are based on non-randomised retrospective and anecdotal trials. In 
patients with elevated ICP who have an ICP monitor, cerebral perfusion pressure 
should be kept > 70 mmHg. Mean arterial blood pressure >II 0 mm Hg should be 
avoided in the immediate postoperative period. If systolic arterial blood pressure falls 
below 90 mmHg, pressors should be given. The suggested management is 
summarized in Table 2.2. 
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Blood Pressure Management in ICH. 
!.Elevated blood pressure (suggested medications) 
Labetolol 5-l 00 mg/h by intermittent bolus doses of l 0-40 mg or continuous drip (2-8 
mg/min). 
Esmolol 500 Jlg/kg as a load; maintenance use, 50-200 J.tg/kg/min. 
Nitroprusside 0.5-10 J.tg/kg/min. 
Hydralazine I 0-20 mg 4-6 hourly. 
1. If systolic BP is > 230 mmHg or diastolic BP > 140mmHg on 2 readings 5 minutes 
apart, institute nitroprusside. 
2. If systolic BP is 180 to 230 mmHg, diastolic BP I 05-140 mmHg, or mean arterial 
pressure > 130 mmHg on 2 readings 20 minutes apart, institute intravenous labetolol, 
esmolol or other small doses of easily titratable intravenous medications such 
diltiazem or verapramil. 
3. If systolic BP is < 180 mmHg and diastolic BP is < 105 mmHg, defer 
antihypertensive therapy. 
4. If ICP monitoring is available, cerebral perfusion pressure should be kept at >70 
mmHg. 
2. Low blood pressure. 
Volume replenishment is the first line of approach. Isotonic saline or colloids can be 
used and monitored with central venous pressure pr pulmonary artery wedge pressure. 
If hypotension persists after correction of volume deficit, continuous infusion of 
pressors should be considered, particularly for low systolic blood pressure such as 
<90mmHg. 
Table 2.2: Guideline by the special writing group of the Stroke Council, American 
Heart Association (AHA)3 on blood pressure management in ICH. 
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